Compare Cloudflare Inc (NET) vs Natera Inc. Common Stock (NTRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cloudflare Inc vs Natera Inc. Common Stock — how do they compare? Cloudflare Inc trades at $319.57 (market cap $123.81B), while Natera Inc. Common Stock trades at $394 (market cap $57.03B). The key difference: Cloudflare Inc is far larger — about 2.2× Natera Inc. Common Stock's market cap, and Cloudflare Inc is more actively traded (1,745,042 versus 1,131,157). Which is the better fit depends on your goals — on Pluang, investors hold Cloudflare Inc for 61 Days and Natera Inc. Common Stock for 0 Days on average.
| NET | NTRA | |
|---|---|---|
Market Cap | $123.81B | $57.03B |
Volume | 1,745,042 | 1,131,157 |
Sector | Technology | Health |
52-Week High | $361.00 | $425.64 |
52-Week Low | $160.16 | $179.42 |
Typical Hold Time | 61 Days | 0 Days |
Enterprise Value | $123.18B | $56.18B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cloudflare (NET) trades at $324.01, down 7.6% over 24 hours, amid a mixed technical and fundamental backdrop. The stock shows a bullish moving average signal but neutral oscillators, with key support at $328. Fundamentally, revenue growth is strong, reaching $2.17B in 2025, but profitability remains a challenge with a net income margin of -8.21%. Recent news highlights product launches like Cloudflare Basin and a partnership with Deutsche Telekom, driving positive sentiment.
The outlook is cautiously optimistic, supported by analyst consensus and strategic initiatives, but high valuation multiples and persistent losses pose risks. Investment opportunity lies in continued top-line expansion and market share gains, while key risks include competitive pressures and execution on path to profitability.
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cloudflare Inc
Cloudflare is a software company based in San Francisco, California, that offers security and web performance offerings by utilizing a distributed, serverless content delivery network, or CDN. The firm's edge computing platform, Workers, leverages this network by providing clients the ability to deploy, and execute code without maintaining servers.
Read more on NET →About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →
